Stockreport

New Study Using Aptar’s Nasal Drug Delivery System Validates Insulin Nasal Spray to Deliver Alzheimer’s Drug Directly to the Brain

AptarGroup, Inc.  (ATR) 
Last aptargroup, inc. earnings: 4/30 05:04 pm Check Earnings Report
US:NYSE Investor Relations: investors.aptar.com
PDF Research by Wake Forest University School of Medicine provides a crucial method for future Alzheimer’s disease treatment trials and reveals key differences in how the dr [Read more]